These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18054286)

  • 1. What's going on in LDL apheresis.
    Onofrillo D; Accorsi P
    Transfus Apher Sci; 2007 Dec; 37(3):213-21. PubMed ID: 18054286
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosorptive apheresis of LDL.
    Borberg H; Gaczkowski A; Oette K; Stoffel W
    Prog Clin Biol Res; 1990; 337():163-7. PubMed ID: 2191310
    [No Abstract]   [Full Text] [Related]  

  • 3. [LDL-apheresis--clinical indication and utility].
    Nakamura T; Ishikawa K
    Nihon Rinsho; 1999 Dec; 57(12):2854-61. PubMed ID: 10638225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heparin-induced extracorporeal LDL precipitation (H.E.L.P.)].
    Horstkotte D; Mellwig KP
    Z Kardiol; 2003; 92(Suppl 3):III1-5. PubMed ID: 14663596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical aspects of direct adsorption of lipoproteins from whole blood by DALI LDL-apheresis.
    Bosch T
    Transfus Apher Sci; 2004 Oct; 31(2):83-8. PubMed ID: 15501411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?
    Ramunni A; Quaranta N; Saliani MT; Fallacara RA; Ria R; Ranieri G
    Ther Apher Dial; 2006 Jun; 10(3):282-6. PubMed ID: 16817795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ACE inhibitors and LDL-apheresis with dextran sulphate adsorption.
    Kroon AA; Mol MJ; Stalenhoef AF
    Lancet; 1992 Dec; 340(8833):1476. PubMed ID: 1360599
    [No Abstract]   [Full Text] [Related]  

  • 8. LDL-Apheresis removes serum amyloid P and A in hypercholesterolemic patients.
    Palumbo B; Cardinali L; Sinzinger H
    Thromb Res; 2000 Mar; 97(6):491-4. PubMed ID: 10704659
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis--implications for rheological studies.
    Schechner V; Ben-Ami R; Hershcovici T; Yedgar S; Beigel Y; Shapira I; Berliner S; Barsthein G
    Ther Apher Dial; 2005 Oct; 9(5):379-84. PubMed ID: 16202011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-mediated extracorporeal low-density lipoprotein precipitation: rationale for a specific adjuvant therapy in cardiovascular disease.
    Blessing F; Wang Y; Walli AK; Seidel D
    Transfus Apher Sci; 2004 Jun; 30(3):255-66. PubMed ID: 15172631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid abnormalities and coronary heart disease.
    Grundy SM
    Clin Symp; 1997; 49(4):1-32. PubMed ID: 9444788
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimization of therapeutic procedure during LDL-apheresis - verification of the computerized model in clinical practice.
    Masin V; Blaha M; Stransky P; Blaha V; Cermanova M; Maly R; Zajic J
    Transfus Apher Sci; 2007 Feb; 36(1):39-45. PubMed ID: 17292673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical effects of direct adsorption of lipoprotein apheresis: beyond cholesterol reduction.
    Bosch T; Keller C
    Ther Apher Dial; 2003 Jun; 7(3):341-4. PubMed ID: 12924610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment methods for LDL apheresis.
    Bertrams A; Strout N
    J Clin Apher; 1994; 9(4):241. PubMed ID: 7759470
    [No Abstract]   [Full Text] [Related]  

  • 15. LDL apheresis in Italy.
    Iacone A
    Transfus Apher Sci; 2007 Dec; 37(3):211-2. PubMed ID: 18042439
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years.
    Palcoux JB; Atassi-Dumont M; Lefevre P; Hequet O; Schlienger JL; Brignon P; Roussel B
    Ther Apher Dial; 2008 Jun; 12(3):195-201. PubMed ID: 18503695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential depletion of selenoprotein P in hypercholesterolaemic patients treated by LDL-apheresis.
    Persson-Moschos M; Bonnefont-Rousselot D; Assogba U; Bruckert E; Jaudon MC; Delattre J; Akesson B
    Clin Chim Acta; 1995 Sep; 240(2):209-12. PubMed ID: 8548930
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease.
    Pusl T; Broedl UC; Parhofer KG; Otto C
    Clin Hemorheol Microcirc; 2009; 41(2):137-42. PubMed ID: 19252236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing low-density lipoprotein apheresis procedures: difficulties and remedies.
    Jovin IS; Taborski U; Müller-Berghaus G
    J Clin Apher; 1996; 11(3):168-70. PubMed ID: 8915823
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-density lipoprotein apheresis: plasma exchange or dextran sulfate adsorption apheresis.
    Yavasoglu I; Kadikoylu G; Bolaman Z
    Ther Apher Dial; 2008 Feb; 12(1):100-1; author reply 102. PubMed ID: 18257822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.